Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826546) titled 'Is Central Sensitization a Prognostic Indicator in Chronic Nonspecific Low Back Pain?' on Sept. 12.

Study Type: Observational

Primary Sponsor: Mardin Artuklu University

Condition: Chronic Nonspecific Low Back Pain

Recruitment Status: Recruiting

Date of First Enrollment: June 1, 2026

Target Sample Size: 180

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07826546

Disclaimer: Curated by HT Syndication....